These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

867 related articles for article (PubMed ID: 19361756)

  • 1. Platelet engraftment in patients with hematologic malignancies following unmanipulated haploidentical blood and marrow transplantation: effects of CD34+ cell dose and disease status.
    Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Yu-Wang ; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):632-8. PubMed ID: 19361756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of CD34+ cell dose on platelet engraftment in pediatric patients following unmanipulated haploidentical blood and marrow transplantation.
    Chang YJ; Xu LP; Liu DH; Liu KY; Han W; Chen YH; Wang Y; Chen H; Wang JZ; Zhang XH; Zhao XY; Huang XJ
    Pediatr Blood Cancer; 2009 Dec; 53(6):1100-6. PubMed ID: 19743519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose.
    Keever-Taylor CA; Klein JP; Eastwood D; Bredeson C; Margolis DA; Burns WH; Vesole DH
    Bone Marrow Transplant; 2001 Apr; 27(8):791-800. PubMed ID: 11477435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing engraftment in HLA-haploidentical/mismatch related transplantation with combined granulocyte-colony stimulating factor-mobilized peripheral blood and bone marrow for patients with leukemia.
    Zhang C; Zhang X; Chen XH; Gao L; Gao L; Kong PY; Peng XG; Sun AH; Wang QY
    Transfus Apher Sci; 2011 Jun; 44(3):249-55. PubMed ID: 21550308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.
    Chang YJ; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):323-34. PubMed ID: 18275899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation].
    Sawada H; Wake A; Yamasaki Y; Izumi Y
    Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure to achieve a threshold dose of CD34+ CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation.
    Sartor MM; Garvin F; Antonenas V; Bradstock KF; Gottlieb DJ
    Bone Marrow Transplant; 2007 Nov; 40(9):851-7. PubMed ID: 17704793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
    Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High CD4/CD8 ratio in allografts predicts adverse outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic stem cell transplantation for chronic myeloid leukemia.
    Xu LP; Luo XH; Chang YJ; Liu DH; Liu KY; Chen YH; Huang XJ
    Ann Hematol; 2009 Oct; 88(10):1015-24. PubMed ID: 19319533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin.
    Dong L; Wu T; Zhang MJ; Gao ZY; Lu DP
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1515-24. PubMed ID: 18022582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploidentical hematopoietic stem cell transplantation in child hematologic malignancies with G-CSF-mobilized marrow grafts without T-cell depletion: a single-center report of 45 cases.
    Wang HX; Yan HM; Duan LN; Wang ZD; Zhu L; Xue M; Liu J; Hu LD; Guo ZK
    Pediatr Hematol Oncol; 2009; 26(3):119-28. PubMed ID: 19382033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
    Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma.
    Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold?
    Singhal S; Powles R; Treleaven J; Kulkarni S; Sirohi B; Horton C; Millar B; Shepherd V; Tait D; Saso R; Rowland A; Long S; Mehta J
    Bone Marrow Transplant; 2000 Sep; 26(5):489-96. PubMed ID: 11019837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmanipulated HLA-mismatched/haploidentical peripheral blood stem cell transplantation for high-risk hematologic malignancies.
    Huang W; Li H; Gao C; Bo J; Wang Q; Zhao Y; Jing Y; Wang S; Zhu H; Dou L; Wang L; Yu L
    Transfusion; 2012 Jun; 52(6):1354-62. PubMed ID: 22233440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched/haploidentical hematopoietic SCT.
    Luo XH; Chang YJ; Xu LP; Liu DH; Liu KY; Huang XJ
    Bone Marrow Transplant; 2009 Jan; 43(1):29-36. PubMed ID: 18776927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
    Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A
    Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.
    González-Vicent M; Molina B; Andión M; Sevilla J; Ramirez M; Pérez A; Díaz MA
    Eur J Haematol; 2011 Jul; 87(1):46-53. PubMed ID: 21692851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.